Sarah Arron, MD, Dermatology, San Francisco, CA, San Francisco VA Medical Center

SarahTuttletonArronMD

Dermatology San Francisco, CA

Dermatologic Surgery

Assistant Professor, Dermatology, UCSF School of Medicine

Dr. Arron is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Arron's full profile

Already have an account?

Education & Training

  • UCSF
    UCSFResidency, Dermatology, 2004 - 2006
  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterInternship, Transitional Year, 2003 - 2004
  • Weill Cornell Medical College of Cornell University
    Weill Cornell Medical College of Cornell UniversityClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - 2022
  • American Board of Dermatology Dermatology
  • American Board of Preventive Medicine Clinical Informatics

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
  • Fellow (FASDS) American Society for Dermatologic Surgery
  • Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Caring for LGBT patients: What dermatologists need to know 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019

Authored Content

  • Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United StatesMay 2020
  • Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United StatesMay 2020

Press Mentions

  • Why Are Gay Men More Likely to Get Skin Cancer?
    Why Are Gay Men More Likely to Get Skin Cancer?February 13th, 2020
  • Castle Biosciences’ Cutaneous Squamous Cell Carcinoma Prognostic Test Development Update Presented at the American College of Mohs Surgery
    Castle Biosciences’ Cutaneous Squamous Cell Carcinoma Prognostic Test Development Update Presented at the American College of Mohs SurgeryMay 7th, 2019
  • Increasing HLA Mismatch May Cut Risk for Skin Cancer
    Increasing HLA Mismatch May Cut Risk for Skin CancerJanuary 29th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations